CONTENIDO

7th HIV Persistence during Therapy

08.12.15 - 11.12.15
Marriott Biscayne Bay.
1633 North Bayshore Drive. Miami, Florida (USA). 

 

Since the first edition of this workshop in 2003 in St Maarten, the issue of HIV Persistence & Reservoirs has become more relevant, not only for the biologist but also for the clinician facing the problem of the long-term control of this persistent retroviral infection.

 

Several meetings have now included reviews on these topics in their program, but this workshop is unanimously recognized as “The Reference Workshop on HIV Reservoirs & Eradication Strategies.” 

 

The program format will continue to follow the past successes and include presentations of new, unpublished data and a panel of experts to sum up the current advances in the field. The number of participants is now limited to 250. As in the past, abstract selection will be extremely rigorous and conducted by the Scientific Committee, focusing on new progress in the field.

 

Please find attached the preliminary program.

Bajar documento (application/pdf)

Publicaciones o ponencias relacionadas con el congreso

  • 10/12/2015 - Long-term Spontaneous control of HIV-1 relates to low frequency of infected cells and inefficient viral reactivation.

    Immunology of HIV Persistence Session Room

    Julia G. Prado - Oral presentation: Long-term Spontaneous control of HIV-1 relates to low frequency of infected cells and inefficient viral reactivation.

     

    (Same presentation will be presented as a poster during the Poster Viewing Session, the 9th and 10th December).

  • 10/12/2015 - CD8 sensing relies on nanomolar levels of antigen presented upon HIVreactivation

     

    Immunology of HIV Persistence Session Room

    Alba Ruiz de AndrésOral presentation: CD8 sensing relies on nanomolar levels of antigen presented upon HIVreactivation.

     

    (Same presentation will be presented as a poster during the Poster Viewing Session, the 9th and 10th December)

  • 08/12/2015 - Low Viral Reservoir Treated patients (LoViReT): clinical predictors of low HIV-1 DNA

    Poster presentation.

    M Salgado1, C Gálvez1, J Dalmau1, J Carrillo1, V Urrea1, B Clotet1,2,3, J Blanco1,3, J Martinez-Picado1,4

     

    1AIDS Research Institute IrsiCaixa, Badalona, Spain; 2Fundació Lluita contra la SIDA, Badalona, Spain;  3Universitat de Vic-Central de Catalunya, UVIC-UCC, Vic, Spain; 4ICREA, Barcelona, Spain.

  • 08/12/2015 - HIV Conserved Region Vaccine in Early cART-Treated Subjects (BCN01): Impact on immunogenicity and the latent reservoir

    Poster and oral presentation.

    S. Morón-López, B. Mothe, C. Manzardo, A. Sanchez-Bernabeu, P. Coll, MC. Puertas, L. Dorrell, JM. Miró, B. Clotet, C. Brander, J. Martinez-Picado and T. Hanke for the BCN01 study group

     

  • 11/12/2015 - SESSION 9: NEW THERAPEUTIC APPROACHES 1

    Chairs: José Gatell, University of Barcelona, Barcelona – SPA, Javier Martinez Picado, University Hospital Germans Trias i Pujol, Barcelona - SPA

     

    - Potential role for neutralizing antibodies in HIV-1 infection. John Mascola, NIAID,...

  • 08/11/2015 - Post-mortem analysis of HIV-1 Reservoir after Allogeneic Transplantation using Stem Cells with a nonfunctional CCR5 (CCR5Δ32) co-receptor

    Poster number PP 3.10 

    From 2:00 pm on Tuesday December 8 until 12 pm on Friday December 11

     

    M Nijhuis (1), A Bruns (1), M Salgado (2), AJ Stam (1), PM Ellerbroek (1), K. Tesselaar (1), P van Ham (1), TCM de Jong (1), G Hutter (3), SS Zeerleder (4), JT van der Meer (4), LLA Brosens (1), J Martinez-Picado (2,5), J Kuball (1), AMJ Wensing (1), for the EpiStem consortium

     

    (1) University Medical Center Utrecht, Utrecht, the Netherlands; (2) AIDS Research Institute irsiCaixa, Badalona, Spain;  (3) Cellex, Dresden, Germany; (4) Academic Medical Center, Amsterdam, the Netherlands; (5) ICREA, Barcelona, Spain.